Medical package testing is done in order to ensure that the package’s seal meets integrity standards. Validation offers the assurance and secure knowledge that the package is properly seals, free of leaks and protected from outside contaminants.
Accelerated aging should be done after package testing has been done.Leak testing or “container closure integrity testing” (CCIT) plays an important part to secure sterility over the shelf life of a product and prevent microbiological, oxygen or moisture ingress into the primary packaging as for example vials, syringes, plastic bottles or pouches.
Various pharmaceutical packaging.Examine all the pockets for any leakage by opening the pockets manually. If any one pocket shows evidence of leakage, reject the sample, stop the Blister / Strip machine and immediately take corrective action.
Again run the machine and then take double number of strips / blister and again repeat the leak test.After the stabilisation, the pressure change in the test piece is compared to the pressure change in the reference volume, using the Transducer. The difference in volume is measured and if a leak is detected the difference will increase.
An alarm limit may be set for a pass/fail decision.
Global medical packaging leak testing system market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
PTI Launches New VeriPac 465 Micro Leak Detection System At Interphex Achieving Sub-Micron Leak Detection.PTI Inspection Systems introduces the new revolutionary VeriPac 465 Micro Leak Detection System at the upcoming Interphex event October 19-21, at the Jacob Javits Center in NYC. This latest generation in PTI’s VeriPac Series will be showcased in Booth 3119.
The VeriPac 465 is a deterministic micro leak test system for container closure integrity testing for parenteral products and rigid containers that require precise measurement and detection of the smallest leaks.
The next generation PERMA-VAC technology addresses vacuum leak detection at the very core of the physical test measurement, controlling the test system volume and maximising the Signal-to-Noise Ratio (SNR) between good and defective samples.
VeriPac 465 technology reduces the baseline measurement for good samples and amplifies the test result for defective samples. This technology is geared towards detecting leaks in the MALL range for medical parenteral packaging and can also be applied to flexible and semi flexible package formats.
© Copyright 2017-2023. Mobility Foresights. All Rights Reserved.